ResearcherIRCCS Istituto Auxologico ItalianoNo recent work listed
Alessandra Dicitore
Matched on ORCID iD 0000-0003-0887-5242; OpenAlex author ID A5068169028. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2012: 1 paper · 2013: 1 paper · 2014: 1 paper
Papers 3
- Type I interferon-mediated pathway interacts with peroxisome proliferator activated receptor-γ (PPAR-γ): at the cross-road of pancreatic cancer cell proliferat… Co-author DOI 10.1016/j.bbcan.2013.11.003↗
- Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy? Co-author DOI 10.2174/1568009611313040008↗
- The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pancreatic cancer cells. Co-author DOI 10.1016/j.biotechadv.2011.08.001↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michele Caraglia · 3 shared papers, 2012–2014 · strength 0.11
- Paper Type I interferon-mediated pathway interacts with peroxisome proliferator activated receptor-γ (PPAR-γ): at the cross-r… DOI 10.1016/j.bbcan.2013.11.003↗
- Paper Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy? DOI 10.2174/1568009611313040008↗
- Paper The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pan… DOI 10.1016/j.biotechadv.2011.08.001↗
- Giovanni Vitale · 3 shared papers, 2012–2014 · strength 0.11
- Paper Type I interferon-mediated pathway interacts with peroxisome proliferator activated receptor-γ (PPAR-γ): at the cross-r… DOI 10.1016/j.bbcan.2013.11.003↗
- Paper Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy? DOI 10.2174/1568009611313040008↗
- Paper The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pan… DOI 10.1016/j.biotechadv.2011.08.001↗
- Leo J. Hofland · 2 shared papers, 2012–2013 · strength 0.06
- Paper Combined treatment with PPAR-γ agonists in pancreatic cancer: a glimmer of hope for cancer therapy? DOI 10.2174/1568009611313040008↗
- Paper The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-β treated pan… DOI 10.1016/j.biotechadv.2011.08.001↗
- Claudio Arra · 1 shared paper, 2014 · strength 0.04
- Alfredo Budillon · 1 shared paper, 2012 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.